Patients harboring HOXD12-positive expression status and HOXD12 gene body hypermethylation in the TCGA formed the class of oligodendrogliomas with the worst outcomes, with a median overall survival of only 2.6 years (Fig. 2f). The gene discussed is HOXD12; the disease is oligodendroglioma.